Liver Metastases News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Public Records: Deaths filed December 15-31 - Evansville Courier & Press



Evansville Courier & Press
 
Public Records: Deaths filed December 15-31 
Evansville Courier & Press
16, 1969, Golconda, Ill.; metastatic adenocarcinoma of the esophagus moderately differentiated, liver metastasis, acute blood loss anemia, bleeding esophageal mass, Dec. 8. Bengert, James L.; Nov. 2, 1951, Evansville; subdural hematoma, blunt force ...

 


Liver-Directed Therapy Shows Improvement in mCRC - OncLive



OncLive
 
Liver-Directed Therapy Shows Improvement in mCRC 
OncLive
OncLive: Please provide an overview of your presentation on liver-directed therapy for patients with metastatic CRC. Kemeny: I discussed direct treatment to the liver. Even though we have new and better drugs for the treatment of CRC, we still have ...

 


Allegheny Health Network now can target and destroy bone tumors - Pittsburgh Post-Gazette



Pittsburgh Post-Gazette
 
Allegheny Health Network now can target and destroy bone tumors 
Pittsburgh Post-Gazette
Nowadays, longer survival of patients with cancer has made the spreading of tumors more common, with metastatic bone cancers occurring in up to 80 percent of patients with such primary malignancies of the breasts, prostate, liver and lungs. ?The spine ...

 


Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the ... - Dove Medical Press



Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the ... 
Dove Medical Press
Purpose: To evaluate the safety and efficacy of degradable starch microspheres (DSM) as embolic agents in transarterial chemoembolization (TACE) in the treatment of secondary liver metastases. Methods: This was a national, multicenter observational ...

 


BioLineRx (BLRX) Reports Partial Monotherapy Results from Phase 2A COMBAT Study in Pancreatic Cancer - StreetInsider.com



BioLineRx (BLRX) Reports Partial Monotherapy Results from Phase 2A COMBAT Study in Pancreatic Cancer 
StreetInsider.com
"The results show that BL-8040 induces robust infiltration of anti-tumor T cells into liver metastases in almost half of the pancreatic cancer patients who underwent a biopsy, effectively transforming these tumors from immunologically 'cold' to 'hot ...

and more » 


Morse Gives His Perspective on Lines of Therapy for a Patient With Metastatic Colorectal Cancer - Targeted Oncology



Targeted Oncology
 
Morse Gives His Perspective on Lines of Therapy for a Patient With Metastatic Colorectal Cancer 
Targeted Oncology
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol. 2015;26(4):702-708. doi: 10.1093/annonc/mdu580. Cremolini C ...

 


Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology - Markets Insider



Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology 
Markets Insider
NEW YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that results of a multi-center retrospective analysis of ...

 


Advanced Bladder Cancer: Predicting Clinical Response - OncLive



OncLive
 
Advanced Bladder Cancer: Predicting Clinical Response 
OncLive
Daniel J. George, MD: Immunotherapy, as exciting as it is in bladder cancer, doesn't respond in everybody. And the reality is that there are patients who we can probably identify up front and who are less likely to respond. These are typically patients ...

and more » 


Delcath Announces Special Protocol Agreement Modification With FDA - Markets Insider



Delcath Announces Special Protocol Agreement Modification With FDA 
Markets Insider
NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has concluded a modification agreement with the U.S ...

and more » 


Bacteria May be Root Cause of Cancer - Edgy Labs (blog)



Edgy Labs (blog)
 
Bacteria May be Root Cause of Cancer 
Edgy Labs (blog)
However, a research team has found evidence that supports the hypothesis that Fusobacterium nucleatum and its associated microbiome, found in the primary tumor cells, travel with metastatic cells to other body parts. Harvard University researchers, in ...